alexa Low-dose Aspirin Improves Renal Function And Antihypertensive Efficacy In Hypertensive Rats Treated With Losartan | 17526
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Nephrology & Therapeutics

Teresa Sousa, Jorge Carvalho, Maria Jo?o Valente, Lu?s Vale, Liliana Almeida, Joana Afonso, Maria Jo?o Martins, F?lix Carvalho and Ant?nio Albino-Teixeira
ScientificTracks Abstracts: J Nephrol Ther
DOI: 10.4172/2161-0959.S1.013
Abstract
T he combined treatment with low-dose aspirin and losartan appears to elicit a higher cardiovascular protection than losartan alone in hypertensive patients but the mechanisms involved have not been elucidated. The acetylation of cyclooxygenase 2 (COX-2) by aspirin induces the synthesis of 15-epi-lipoxins (15-epi-LXs) which act as stop signals in inflammation and also limit oxidative damage, induce vasodilation and improve renal function. The study was aimed at evaluating if low-dose aspirin improves renal function and the antihypertensive efficacy in hypertensive rats treated with losartan and whether this putative protective effect is associated with changes in COX-2 derived eicosanoids and oxidative stress. Twelve week-old spontaneously hypertensive rats (SHR) were assigned to 4 groups: control, aspirin (10 mg/kg/day, 8 days), losartan (15 mg/kg/day, 8 days) and losartan+aspirin (8 days). Systolic blood pressure (SBP), renal function, renal COX-2 expression and the plasma and/or urinary levels of 15-epi-LXA4, 11-dehydro-thromboxane B2 and 8-isoprostane were evaluated. The combined treatment with aspirin and losartan in SHR was associated with significantly lower levels of systolic blood pressure, proteinuria, plasma urea, plasma uric acid, urinary excretion of 11-dehydro-thromboxane B2 and 8-isoprostane and renal COX-2 expression, when compared to losartan alone. Urinary 15-epi-LXA4 was also tendentially higher in SHR treated with aspirin or losartan+aspirin. Thus, it is concluded that the addition of low-dose aspirin to losartan improves the antihypertensive efficacy and renal function in SHR. These effects appear to be related to a reduced ratio between renal eicosanoids with vasoconstrictor and pro-inflammatory activity (thromboxane A2, 8-isoprostane) and those with vasodilator, anti-inflammatory and antioxidant properties (15-epi-LXs)
Biography
Teresa Sousa, PharmD (1999), PhD in Pharmacology (2006), is an Investigator at the Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto. Her major research interests are oxidative stress, renin-angiotensin system and resolution of inflammation mediators in arterial hypertension and heart failure. She has received several prizes/awards, including the Poster Award from EPHAR, the Lars-Erik Gelin Conference Travel Award from the European Society for Microcirculation, the Young Investigator Prize from the Calouste Gulbenkian Foundation, the Young Investigator Prize from the Portuguese Society of Hypertension and the Alberto Ferrari Poster Prize from the European Society of Hypertension.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7